Anders Rylander
CEO
Replay available
Biovica International AB (publ) (STO: BIOVIC_B) Q1 2025 earnings conference call, held 2024-09-12. Replay captured from the company's public earnings webcast.

CEO
CFO
Head of US Operations
Head of Business Development and Pharma Services
Watch the replay and follow the connected company analysis, news, and investor updates for Biovica International Ab Class B.
WEBVTT 00:00:00.031 -- 00:00:05.938 Hello everyone and welcome to the Byvika Q1 Interim Report. 00:00:06.321 -- 00:00:11.610 Today it will be me Anders Rylander together with my CFO Anders Morén 00:00:11.610 -- 00:00:17.200 and Hector Tamburini, Head of US Operations and Henrik Winter, 00:00:17.200 -- 00:00:22.228 Head of Business Development and Pharma Services who will be presenting and the 00:00:22.228 -- 00:00:25.674 agenda will be a short introduction about the company. 00:00:25.674 -- 00:00:31.302 We'll focus on the Q1 highlights. Anders will go into the financials. 00:00:31.302 -- 00:00:34.106 Hector will give an update about the U.S. progress. 00:00:34.106 -- 00:00:37.190 And Henrik will do the same for pharma services. 00:00:37.190 -- 00:00:42.418 And at the end, there will be a summary and we'll open up for a Q&A session. 00:00:42.418 -- 00:00:47.745 The way the Q&A session will work is that first we will let our analysts, 00:00:47.745 -- 00:00:51.442 financial analysts in. which you see here on the screen. 00:00:51.442 -- 00:00:56.631 Johan from Redeye and we have Paretta and Luisa from 00:00:56.631 -- 00:01:00.598 Kempen also. You can also submit 00:01:00.598 -- 00:01:04.625 questions in the chat window. And 00:01:04.625 -- 00:01:07.530 if we have time, we will try to limit this to one hour. 00:01:07.530 -- 00:01:11.210 We will answer these questions from the chat as well. 00:01:11.210 -- 00:01:16.319 in the webcast and all questions that we can answer, 00:01:16.319 -- 00:01:21.408 we will also answer in writing and add it as an appendix to the presentation that will 00:01:21.408 -- 00:01:24.350 be uploaded after the meeting. 00:01:25.576 -- 00:01:30.705 So if I start with a very short introduction of BioVica, what we do, 00:01:30.705 -- 00:01:35.459 we h...